High-content screening (HCS), a technology based on subcellular imaging by automated microscopy and sophisticated image analysis, has emerged as an important platform in small-molecule screening for early drug discovery. To validate a subcellular imaging assay for primary screening campaigns, an HCS assay was compared with a non-image-based readout in terms of variability and sensitivity. A study was performed monitoring the accumulation of the forkhead transcription factor of the O subfamily (FOXO3a) coupled with green fluorescent protein in the nucleus of human osteosarcoma (U-2 OS) cells. In addition, the transcription of a luciferase gene coupled with a FOXO3a-responsive promoter was monitored. This report demonstrates that both assay formats show good reproducibility in primary and concentration response screening despite differences in statistical assay quality. In primary screening, the correlation of compound activity between the 2 assays was low, in contrast to the good correlation of the IC 50 values of confirmed compounds. Furthermore, the high-content imaging assay showed a mean shift of 2.63-fold in IC 50 values compared with the reporter gene assay. No chemical scaffold was specifically found with 1 of the technologies only, however these results validate the HCS technology against established assays for screening of new molecular entities. (Journal of Biomolecular Screening 2009:59-65) high-throughput screening of small molecules, enabling new strategies in early drug discovery. [9] [10] [11] [12] [13] The phospho-inositol-3 kinase (PI3K) pathway is one of the major antiapoptotic pathways in cells, being activated in response to a wide range of trophic signals, including soluble growth factors and attachment to the extracellular matrix. 14 The PI3K pathway and the assay principle are shown in Figure 1. Triggering the PI3K pathway leads to activation of the protein kinase Akt, resulting in protection of cells from programmed death. Akt alters the transcriptional response to apoptotic stimuli, for example, by acting on FOXO transcription factors and influencing the activity of the p53 family. 15 The phosphorylation of FOXO by Akt, in the case of FOXO3a at the threonine 32, serine 253, and serine 315 sites, 16 induces its redistribution from the nucleus to the cytosol, thereby reducing its transcriptional activity. 17-19 Compounds inhibiting the PI3K pathway decrease phosphorylation of FOXO transcription factors; hence, nonphosphorylated FOXO accumulate in the nucleus, activating transcription of proapoptotic genes. 20 With FOXO3a transcription factor fused to the green fluorescent protein (GFP), both the High Content and Reporter Gene Assay Comparison Journal of Biomolecular Screening 14(1); 2009 www.sbsonline.org 61 FIG. 2. FOXO3a-GFP distribution in U-2 OS cells. (A) DMSO control cells. (B) Phospho-inositol-3 kinase inhibitor-treated cells.
INTRODUCTION
S UBCELLULAR IMAGING using confocal and nonconfocal microscopy has been available for more than 20 years. However, recent technological advances in high-content instrumentation and image analysis have increased ease of use and throughput, sparking interest for its application to screen compounds or genes involved in cellular processes. 1, 2 One main characteristic of cellular imaging is the ability to monitor multiple events, which has been used to describe multidimensional phenotypic profiles upon compounds treatment. [3] [4] [5] [6] Transient cellular events can be examined by live cell analysis, whereas the evaluation of the population of cells allows the detection of rare cellular events. 7, 8 An application in which high-content screening increasingly shows its benefit is the medium-to translocation event and the activation of transcription can be used as readouts to identify inhibitors of the PI3K pathway as potential drug candidates in cancer treatment. [21] [22] [23] To identify the optimal screening strategy for lead-finding campaigns influencing the PI3K pathway, a high-content assay (HCA) of FOXO nuclear accumulation was compared with a non-imagebased reporter gene assay (RGA) in terms of variability and sensitivity.
This report describes a study to determine the interday variability of 2 assay setups: a subcellular imaging assay based on the accumulation of FOXO3a-GFP in the nucleus as well as the RGA based on a transcription of firefly luciferase induced by FOXO3a. Therefore, the results generated by each assay were the consequence of the inhibition of the same cellular pathway. The nuclear accumulation of FOXO3a-GFP in the nucleus of U-2 OS cells upon PI3K inhibitor treatment can be visualized by subcellular imaging, which is shown in Figure 2 in comparison to control cells without inhibitor compound. A set of 3167 compounds including known kinase inhibitor scaffolds were screened 3 times on different days in both assay formats. The interday variability was determined by assessing the quality (Z′ factor, 24 signal-to-background ratio [S/B] 25 ) and the proportionality of the assays by using a correlation plot and derived correlation coefficient. In addition, the agreement between the respective data sets was estimated using the Bland-Altman method. 26 Two days before the assay, cells were detached with trypsin/EDTA (No. 25300-062; Gibco) and counted with the Cedex counter (Innovatis, Bielefeld, Germany), and 15 million cells were seeded in cell culture flasks (No. 132913; Nunc).
MATERIALS AND METHODS

Reporter gene assay
One day before the assay, the cells were transiently transfected with 70.5 µg of pFKHR-LUC plasmid (LR0023; Panomics, Fremont, CA) per T500 flask using lipofectamine On the day of the experiment, 5 µl of 5× concentrated compound dissolved in DMSO and diluted in U-2 OS growth medium was dispensed into the assay plates using the CyBi-Well (CyBio, Jena, Germany). The end concentrations of the compounds were 10 µM for the primary screen and 16 µM for the confirmation screen. The final concentration of DMSO was 0.5% of the assay volume for the primary screen and 0.8% for the confirmation screen. As positive control (designated as PosCtrl), the PI3-kinase inhibitor, Wortmannin (No. W-1628; Sigma, St. Louis, MO), was dissolved in DMSO to a concentration of 5 µM and DMSO only was used as negative control (designated as NegCtrl), both further diluted in growth medium. Cells were incubated for 12 h at 37°C with 5% CO 2 and 95% relative humidity. Then, 15 µl of Steady-Glo (No. E2550; Promega, Madison, WI) were dispensed into the assay plates using a Multidrop (Thermo Fisher Scientific), and the plates were shaken for 20 min at room temperature (RT). The luminescence signal was read on the Viewlux (Perkin Elmer, Turku, Finland) with a reading time of 60 s and a binning factor of 3.
Imaging assay
The FKHRL1_U2OS cells were cultivated at 37°C with 5% CO 2 and 95% relative humidity. Cells were detached using 0.25% trypsin/1 mM EDTA and seeded in a volume of 20 µl with a density of 4000 cells/well on 384-well assay plates (No. 3985; Corning, Corning, NY). On the day of the experiment, 5 µl of 5× concentrated compound dissolved in DMSO and diluted in U-2 OS growth medium was dispensed into the assay plates using the CyBi-Well (CyBio). The same compound concentrations and the same positive and negative controls as in RGA were used. After 1 h of compound incubation, the cells were fixed and the nuclei stained by adding 25 µl of a solution containing 8% paraformaldehyde (PFA; No. 15714-S; Electron Microscopy Sciences, Hatfield, PA) and 1 µM DRAQ5 (No. BOS-889-001-R200; Alexis, Lausen, Switzerland). After incubation for 15 min in the dark at RT, the PFA-DRAQ5 solution was aspirated and 50 µl phosphate buffer saline solution was pipetted into the wells. The plates were sealed with Silverseal aluminum foil (No. 676090; Greiner bio-one) and kept at 4°C until imaging.
Images were acquired using IN Cell Analyzer 3000 automated cell imager (GE Healthcare Bio-Sciences, Piscataway, NJ). Flat field correction was done using a plate with various mixtures of Oregon Green (No. D-6145; Molecular Probes, Carlsbad, CA), Cy5 calibration reagent (No. PA05111; GE Biosciences), and Alexa Fluor 350 carboxylic acid (No. A10168; Molecular Probes). Images for the nuclear stain DRAQ5 and for GFP were taken on 2 different channels with 2 CCD cameras simultaneously. DRAQ5 was excited with the 647 nm Krypton laser, and the 695/BP55 emission filter was used to collect the emitted light. GFP was excited with the 488 nm line of the argon laser, and the 535/BP45 emission filter was used to collect the emitted light. The exposure time for both channels was 1.7 ms.
The localization of FOXO3a-GFP was analyzed with the Nuclear Trafficking analysis module of the IN Cell Analyzer 3000 software using the ratio of nuclear and cytoplasmic intensities (Nuc/Cyt) as readouts. PI3K pathway inhibitors and inhibitors of nuclear export result in an accumulation of FOXO3a-GFP in the nucleus, which is indicated by a high ratio value.
Data analysis
To determine the percentage of inhibition, raw data were normalized to the controls (Wortmannin [PosCtrl] and 0.5% DMSO [NegCtrl]) using the following formula: 100 × ((Sample-NegCtrl)/(PosCtrl-NegCtrl)). Z′ values were calculated according to the formula 24 
The nonparametric Spearman (rank) correlation coefficient ρ was calculated using the software R (version 2.6.1). 27 The nonparametric correlation coefficient was chosen to minimize effects of nonnormal distribution shapes and of data points with high leverage. The usual linear (Pearson) correlation coefficient can give distorted results under these conditions. For the agreement analysis, PI3K inhibitors were tested on 3 different days independently in the HCA and RGA. The concentrationresponse curve (CRC) data were fitted with a 4-parameter logistic function using the Origin  software package (Origin, Northampton, MA), and the IC 50 values were transformed to the logarithmic (log) scale. The standard deviation (SD) of the log IC 50 values was calculated for each compound. To normalize the variation between the SD of each compound measurement, a pooled standard deviation (SD pooled ) for SD HCA or SD RGA was used 28 :
where n 1 to n k were the numbers of measurements performed with each compound and s 1 to s k were the SDs of the respective log IC 50 values. To assess agreement between assays, the combined variance of the 2 assays' SD agreement was determined by the following formula:
RESULTS
For assessment of the interday variability in the HCA and RGA, a set of 3167 compounds was tested in both assays at a single concentration on 3 different days. Thereafter, the percentage of inhibition normalized to the control was calculated. For confirmation experiments, compounds with a median activity of at least 3 SDs higher than the average of all compounds in both assays were tested in addition to a set of known PI3K inhibitors on 3 individual days in both assay formats.
To determine the statistical quality of each experiment, the S/B and Z′ parameter were determined for each day and assay format ( Table 1 ). Despite the low S/B ratio (1.9-2.8) in the HCA, the Z′ was excellent, with an average of 0.62 for the primary screens and 0.54 for the confirmation experiments. Conversely, in the RGA, the S/B was higher (7.6-12.3), but the Z′ was lower with an average of 0.4 for both primary and confirmation experiments, which is still in an acceptable range for screening according to Zhang et al. 24 Because of the transient transfection of the pFKHR-LUC plasmid, a higher variability was expected in this assay.
The correlation between 3 individual screening days was determined by calculating the Spearman rank correlation coefficient ρ as described in the Materials and Methods section. As shown in Table 2 , the different correlation coefficients of HCA primary data sets range from 0.61 to 0.74, indicating a good interday correlation. The corresponding correlation coefficients of the RGA data sets was excellent, with ρ factors ranging from 0.77 to 0.89. In confirmation, the interday correlation of IC 50 values was even higher in both assay formats, with a correlation coefficient ρ of 0.97 to 0.99 (HCA) and 0.90 to 0.96 (RGA). In addition, as shown in Figure 3 , the line of best fit (full line) follows-with a very small drift in the high inhibition range-the line of equality (dashed line), indicating that the data sets are almost equivalent.
The intertechnology correlation of primary screening data was low, indicated by a low correlation coefficient ρ of 0.15, visualized in Figure 4 . From the primary screen, a compound was defined as a hit when having an activity of at least 3 SDs above the average of all compounds. This resulted in a total number of 116 hits: 53 from the RGA and 63 from the HCA. The comparison between the 2 technologies revealed only a small overlap of the primary hits: 25 of the 116 compounds. In addition to these hits, 27 PI3K pathway inhibitors found in a previous screen, using the same technologies, were chosen to be confirmed with CRC experiments.
Fifty-six compounds confirmed in both assays with IC 50 values <16 µM (in at least 2 of 3 experiments) were used for further analysis. To assess the correlation and the level of agreement between HCA and RGA, 2 different methods were used. First, the correlation of the IC 50 values was evaluated in a manner similar to the procedure used for primary screening data sets, except that a logarithmic transformation of the potency measurement was performed to facilitate the visualization of the validation data ( Figure 5) . Second, the agreement between the data sets for both assay formats was assessed using the Bland-Altman method. The calculation of the limits of agreement consisted of determining the mean of the logarithmic potency differences ∆ log (IC 50 ) and the associated standard deviation SD agreement . The limits of agreement are then given by mean (∆ log (IC 50 )) ± 2 SD agreement . 27 A significant correlation between the 2 data sets shown in Figure 6A is obvious with a rank correlation coefficient ρ of 0.61. In addition, 99% of all data points lie below the line of equality, indicating that a given potency measurement obtained with one assay technology is lower than the corresponding measurement obtained with the other assay format.
Here, the RGA revealed lower potencies than HCA, indicating a higher sensitivity of the imaging assay. To derive additional information on the level of agreement between HCA and RGA, the Bland-Altman method was used (Fig. 6B) . The pooled standard deviations (SD pooled ) for each assay format were calculated and the combined variance of 2 different assay technologies (SD agreement ) was determined according to the formulas described in the Materials and Methods section. The 2SD agreement value was used to define the upper and lower limits of agreement and was displayed in the Bland-Altman plot together with the mean difference of the logarithmic IC 50 values (Fig. 6B) .
The difference in the measurements between the 2 assays was consistent such that no potency trends were observed and that 52 of 56 compounds (93%) fell within the limits of agreement. Therefore, it can be concluded that the data are in agreement, except for a constant bias of +0.42 log units, again revealing a lower sensitivity of the RGA. The shift in sensitivity was also reflected in the CRCs exemplified in Figure 7 , which show the effect of an identified PI3K inhibitor active in both HCA and RGA. The IC 50 values of that compound were 1.19 µM in HCA and 7.00 µM in RGA, which correspond to a shift of 5.9-fold.
The comparison of IC 50 values between HCA and RGA revealed that several compounds were active only in HCA because of the difference in sensitivity of the assay formats. Compounds having an IC 50 value close to the highest concentration tested (16 µM) were detectable only in HCA but not in RGA.
DISCUSSION
This report demonstrates that high-content imaging is a sensitive technology with good statistical quality, giving reproducible results that are comparable and, in this example, more sensitive than conventional assay formats such as RGAs. Despite a lower S/B, the statistical quality of HCA as assessed by the Z′ values was higher than that of RGA. This might be because the RGA readout is more downstream of the translocation, where the probability of events influencing the readout is increased. In addition, the transient transfection performed in the RGA decreased the cell viability, and therefore, increased signal variation could reduce the Z′ value. The correlation coefficient ρ measures the strength of a relation between 2 variables. A high value indicates a strong systematic relationship between 2 data sets, whereas a low coefficient does not necessarily indicate a weak one. It could be nonlinear, leading accidentally to smaller correlation values. The use of the Spearman correlation coefficient ρ minimizes data range, leverage point, and nonnormality effects because only the rank order of measured values is relevant. To assess the quantitative level of agreement of the results based on the 2 assay technologies, and not only the relationship (as done with correlation analysis), IC 50 data sets were also analyzed using the Bland-Altman methodology and the related plots.
In each technology (intra-assay correlation), the primary screening data sets obtained on different days correlated very well, showing good reproducibility of both assay formats on different days. The comparison of the correlation and agreement levels between the nuclear translocation and the reporter gene technology required the use of assays measuring the activation of the same pathway to minimize differences due to biology and to reduce as much as possible the probability of unspecific action of the compounds. However, the fact that HCS is measuring an early step whereas the reporter gene readout is reflecting one of the last steps of the response to PI3K inhibitors might affect the sensitivity of the assays.
Comparing the mean inhibition values of the compounds tested in each technology, a very low correlation of the primary data sets between HCA and RGA was found (ρ = 0.15). The assays were optimized separately for incubation times to optimize S/B and the sensitivity of each technology. The lack of correlation could be explained by the difference in compound incubation time, which varied with the assay type (1 h for HCA and 12 h for RGA), meaning that potent but cytotoxic compounds may be active in the imaging assay but appear inactive in the RGA due to loss of cells. In addition, it is more likely to find unspecific compounds in the transcription assay because of more potential interference points. Furthermore, unspecific reporter gene expression activators as well as other members of the FOXO family can activate the expression of the luciferase reporter gene and could account for discrepancies between the 2 assays. In the translocation assay, unspecific nuclear export inhibitors were detected in the hit list, which were later recognized by means of a counterscreen with an unrelated nuclear translocation signal.
To estimate the correlation and agreement of the 2 technologies, the comparison methods were subsequently applied to the IC 50 values of compounds identified as actives in the primary screens. A bias of the IC 50 toward RGA was revealed, indicating that the RGA was 2-to 4-fold less sensitive than the HCA. Several hypotheses can be raised to explain the difference in sensitivity. It is known that transient transfection induces cellular stress and can provoke apoptosis. This effect could lead to a loss of signal, resulting in a lower sensitivity of the RGA. In addition, the transcription of the luciferase gene is most probably not the only event triggered by FOXO accumulation in the nucleus. In addition to the artificial promoter of the luciferase gene, the transcription factor can also bind to the endogenous FOXO3a responsive promoters, leading to reduced transcription of the luciferase gene and to reduced sensitivity.
One point that we wanted to investigate was whether it is possible to find different compound scaffolds by using the different technologies. Scaffolds were identified that were more potent in HCA than in RGA; however, this result was related more to a shift in sensitivity than to a different mode of action detected by only 1 technology. In conclusion, with the set of compounds used in this study, no chemical scaffold was found exclusively in one type of assay technology; however, scaffolds represented 
